COMP <GO>
MCK vs ABBV // OPERATING MARGIN
McKesson Corporation (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: MCK 7
— ABBV 7
▲ OPERATING MARGIN LEADER: ABBV
LAST: $994.58 (+1.40%) • MKT CAP: $114.36B
operating-margins
1.50%
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
operating-margins
24.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MCK VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MCK | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 3.60% | 70.20% | -66.60 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 38.60% | 29.00% | +9.60 | MCK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.5x | 33.3x | -13.80 | MCK | /valuation <GO> |
| Free Cash Flow Yield | 5.00% | 3.47% | +1.53 | MCK | /fcf-yield <GO> |
| Operating Margin ACTIVE | 1.50% | 24.60% | -23.10 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 1.20% | 6.90% | -5.70 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 12.40% | 8.60% | +3.80 | MCK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.33% | 2.27% | -1.94 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.96 | 5.33 | +1.63 | MCK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 7.40% | -0.70 | MCK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.7 | 72.8 | -12.12 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 1.15 | -0.20 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.2x | 113.1x | -92.90 | MCK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $114.36B | $513.86B | -$399.50B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MCK REV | ABBV REV | MCK GROSS % | ABBV GROSS % | MCK FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $403.43B | $61.16B | 3.6% | 70.2% | $5.72B | $17.82B |
| FY 2024 | $359.05B | $56.33B | 3.7% | 70.0% | $5.55B | $17.83B |
| FY 2023 | $308.95B | $54.32B | 44.0% | 44.0% | -$9.59B | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MCK // BETA 0.95
ABBV // BETA 1.15